Search for Clinical Trial Results

Meningeal Carcinomatosis - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis Condition: Meningeal Carcinomatosis Date: 2015-10-26 Interventions: Drug: methotrexate The quantity of methotrexate is different in the two groups. |
Terminated |
Study Name: Depocyt® With Sorafenib in Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-08-24 Interventions:
|
Completed |
Study Name: A Pilot Study of Bevacizumab for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-06-18 Interventions: Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
Terminated |
Study Name: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-08-13 Interventions:
|
Completed |
Study Name: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-12-21 Interventions:
|
Terminated |
Study Name: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis Condition: Leptomeningeal Carcinomatosis Date: 2007-09-07 Interventions: Drug: RTA 744 Aqueous solution of RTA 744 is packaged in 5 ml vials - 1 mg/ ml. The drug is mixed in D10 |
Terminated |
Study Name: Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases Condition: Meningeal Carcinomatosis Date: 2012-10-22 Interventions: Procedure: lumbar puncture |
Terminated |
Study Name: DepoCyt for Active Lymphomatous or Leukemic Meningitis Condition:
Date: 2007-08-31 Interventions: Drug: cytarabine liposome injection 50 mg intrathecal every 14 days for 8 doses, then every 28 days for |
Recruiting |
Study Name: Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis Condition:
Date: 2011-05-24 Interventions: Drug: Trastuzumab One injection per week during 8 weeks by lumbar puncture or Ommaya Reservoir. 4 levels |
Recruiting |
Study Name: Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases Condition: Meningeal Carcinomatosis Date: 2013-03-18 Interventions: Drug: 2B3-101 50 mg/m2 2B3-101 intravenous 3-weekly administration |